Curable composition, cured product thereof, optical member and optical device

Patent metadata

Field	Value
Publication number	US-10018810-B2
Application number	US-201314424935-A
Country	US
Kind code	B2
Filing date	Aug 22, 2013
Priority date	Aug 31, 2012
Publication date	Jul 10, 2018
Grant date	Jul 10, 2018

Abstract

An object of the present invention is to provide a curable composition that can be cured satisfactorily and can form a cured product having a high glass transition temperature as maintained and having high mechanical strength. A curable composition includes a siloxane (A), a cycloaliphatic epoxide (B), and a curing agent (C). The siloxane (A) contains at least two epoxy groups per molecule. The cycloaliphatic epoxide (B) in the curable composition is preferably a compound represented by Formula (I):

wherein X is selected from a single bond and a linkage group.

First claim

The invention claimed is:

1. A curable composition comprising:
a cycloaliphatic epoxide (A);
a siloxane (B) comprising at least two epoxy groups per molecule;
a curing agent (C); and
a hydrogenated glycidyl ether epoxide;
wherein the siloxane (B) is one or more compounds represented by the following formulae:

wherein the content of the hydrogenated glycidyl ether epoxide is 5 to 40 percent by weight based on the total amount (100 percent by weight) of curable compounds contained in the curable composition.

2. The curable composition according to claim 1 ,
wherein the cycloaliphatic epoxide (A) comprises a compound represented by Formula (I):

wherein X is selected from a single bond and a linkage group.

3. The curable composition according to claim 1 ,
wherein the siloxane (B) comprising at least two epoxy groups per molecule comprises a cycloaliphatic epoxy group as at least one of the epoxy groups.

4. The curable composition according to claim 1 ,
wherein the curable composition comprises the cycloaliphatic epoxide (A) in a content of from 5 to 60 percent by weight based on the total amount (100 percent by weight) of the curable composition.

5. The curable composition according to claim 1 ,
wherein the cycloaliphatic epoxide (A) comprises 3,4,3′,4 ′-diepoxybicyclohexyl.

6. The curable composition according to claim 1 , as a composition for optical element formation.

7. The curable composition according to claim 1 , as a composition for a wafer-level lens.

8. A cured product of the curable composition according to claim 1 .

9. An optical element comprising
a cured product of the curable composition according to claim 6 .

10. An optical device comprising
the optical element according to claim 9 .

11. A method for producing a wafer-level lens, the method comprising
subjecting the curable composition for a wafer-level lens according to claim 7 to one of cast molding and injection molding.

12. The method for producing a wafer-level lens, according to claim 7 ,
wherein a cast molding or an injection molding comprises the steps of:
1a or 1b) preparing a wafer-level-lens mold comprising at least one lens pattern;
2a or 2b) bringing or injecting the curable composition for a wafer-level lens into contact with the wafer-level-lens mold; and
3a or 3b) applying at least one of heat and light to the curable composition for a wafer-level lens to cure the curable composition to thereby give a cured product of the curable composition.

13. The method for producing a wafer-level lens, according to claim 12 ,
wherein the cast molding or the injection molding further comprises, after the step 3a or 3b), the step of
4a or 4b) annealing the cured product of the curable composition for a wafer-level lens.

14. The method for producing a wafer-level lens, according to claim 12 ,
wherein the cast molding further comprises, after the step 3a), the step of
5a) cutting the cured product of the curable composition for a wafer-level lens.

15. A wafer-level-lens sheet obtained by the method for producing a wafer-level lens according to claim 12 .

16. A wafer-level lens obtained by the method for producing a wafer-level lens according to claim 11 .

17. An optical device comprising
the wafer-level lens according to claim 16 .

18. A wafer-level lens stack comprising
a plurality of wafer-level lenses,
the plurality of wafer-level lenses constituting the stack comprising a wafer-level lens obtained by curing and molding the curable composition for a wafer-level lens according to claim 7 .

19. A curable composition, comprising:
a cycloaliphatic epoxide (A);
a siloxane (B) comprising at least two epoxy groups per molecule;
a curing agent (C);
a hydrogenated glycidyl ether epoxide; and
an oxetane compound;
wherein the siloxane (B) comprises a cyclic siloxane and that the cyclic siloxane comprises 4 to12 Si—O units,
wherein the content of the hydrogenated glycidyl ether epoxide is 5 to 40 percent by weight based on the total amount (100 percent by weight) of curable compounds contained in the curable composition, and
wherein the content of the oxetane compound is 5 to 30 percent by weight based on the total amount (100 percent by weight) of curable compounds contained in the curable composition.

20. The curable composition according to claim 19 ,
wherein the cycloaliphatic epoxide (A) comprises a compound represented by Formula (I):

wherein X is selected from a single bond and a linkage group.

21. A curable composition comprising:
a cycloaliphatic epoxide (A);
a siloxane (B);
a curing agent (C); and
a hydrogenated glycidyl ether epoxide;
wherein the siloxane (B) is represented by Formula (1)

wherein R 1 and R 2 are, independently in each occurrence, selected from alkyl and a monovalent group containing a cycloaliphatic epoxy group, where at least two occurrences of R 1 and/or R 2 in the compound represented by Formula (1) are each independently a monovalent group containing a cycloaliphatic epoxy group; and q represents an integer of 3 or more.

22. The curable composition according to claim 21 ,
wherein the content of the hydrogenated glycidyl ether epoxide is 5 to 40 percent by weight based on the total amount (100 percent by weight) of curable compounds contained in the curable composition.

23. The curable composition according to claim 21 ,
wherein the cycloaliphatic epoxide (A) comprises a compound represented by Formula (I):

wherein X is selected from a single bond and a linkage group.

Assignees

• Daicel Corp

Inventors

• Kubo Takashi
• Takenaka Hiroki

Classifications

• G02B1/041

  Lenses · CPC title

• C08G59/226

  Mixtures of di-epoxy compounds · CPC title

• C08G77/18

  to alkoxy or aryloxy groups · CPC title

• C08G59/24 Primary

  carbocyclic · CPC title

• C08G59/3218

  Carbocyclic compounds · CPC title